FI830898L - Sulfonylureor, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutiskaprodukter och deras anvaendning - Google Patents

Sulfonylureor, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutiskaprodukter och deras anvaendning

Info

Publication number
FI830898L
FI830898L FI830898A FI830898A FI830898L FI 830898 L FI830898 L FI 830898L FI 830898 A FI830898 A FI 830898A FI 830898 A FI830898 A FI 830898A FI 830898 L FI830898 L FI 830898L
Authority
FI
Finland
Prior art keywords
deras
sulfonylureor
pharmaceutiskaprodukter
baserade
pao
Prior art date
Application number
FI830898A
Other languages
English (en)
Finnish (fi)
Other versions
FI830898A0 (fi
FI830898A7 (fi
Inventor
Volker Hitzel
Rudi Weyer
Karl Geisen
Harald Ritzel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI830898A0 publication Critical patent/FI830898A0/fi
Publication of FI830898A7 publication Critical patent/FI830898A7/fi
Publication of FI830898L publication Critical patent/FI830898L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI830898A 1982-03-19 1983-03-17 Sulfonylureor, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutiskaprodukter och deras anvaendning FI830898L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823210063 DE3210063A1 (de) 1982-03-19 1982-03-19 Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (3)

Publication Number Publication Date
FI830898A0 FI830898A0 (fi) 1983-03-17
FI830898A7 FI830898A7 (fi) 1983-09-20
FI830898L true FI830898L (fi) 1983-09-20

Family

ID=6158708

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830898A FI830898L (fi) 1982-03-19 1983-03-17 Sulfonylureor, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutiskaprodukter och deras anvaendning

Country Status (12)

Country Link
EP (1) EP0089597A3 (enrdf_load_html_response)
JP (1) JPS58170760A (enrdf_load_html_response)
KR (1) KR840004081A (enrdf_load_html_response)
AU (1) AU1266383A (enrdf_load_html_response)
DE (1) DE3210063A1 (enrdf_load_html_response)
DK (1) DK125583A (enrdf_load_html_response)
ES (1) ES8401946A1 (enrdf_load_html_response)
FI (1) FI830898L (enrdf_load_html_response)
GR (1) GR77163B (enrdf_load_html_response)
NO (1) NO830966L (enrdf_load_html_response)
PT (1) PT76411B (enrdf_load_html_response)
ZA (1) ZA831910B (enrdf_load_html_response)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087758B2 (en) * 2001-04-06 2006-08-08 Smithkline Beecham Corporation Quinoline inhibitors of hyaki and hyak3 kinases
AR082734A1 (es) * 2010-08-27 2012-12-26 Gruenenthal Gmbh Quinolino-3-carboxamidas sustituidas como moduladores de kcnq2/3
RU2581362C2 (ru) 2010-08-27 2016-04-20 Грюненталь Гмбх Замещенные 2-оксо- и 2- тиоксо- дигидрохинолин-3-карбоксамиды в качестве модуляторов kcnq2/3
CA2809341A1 (en) * 2010-08-27 2012-03-01 Gruenenthal Gmbh Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
TW201211007A (en) 2010-08-27 2012-03-16 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
AR082813A1 (es) 2010-09-01 2013-01-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
WO2014120815A1 (en) * 2013-01-31 2014-08-07 Vertex Pharmaceuticals Incorporated Quinoline and quinazoline amides as modulators of sodium channels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819633A (en) * 1970-04-01 1974-06-25 Erba Carlo Spa (iso)quinolyl sulfonylureas having antidiabetic activity
DE2621958A1 (de) * 1976-05-18 1977-12-08 Hoechst Ag Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
DE3134780A1 (de) * 1981-09-02 1983-03-10 Hoechst Ag, 6000 Frankfurt "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"

Also Published As

Publication number Publication date
EP0089597A3 (de) 1984-05-09
DK125583D0 (da) 1983-03-18
FI830898A0 (fi) 1983-03-17
AU1266383A (en) 1983-09-22
GR77163B (enrdf_load_html_response) 1984-09-10
JPS58170760A (ja) 1983-10-07
KR840004081A (ko) 1984-10-06
PT76411A (de) 1983-04-01
FI830898A7 (fi) 1983-09-20
DE3210063A1 (de) 1983-09-22
PT76411B (de) 1985-12-16
ZA831910B (en) 1983-11-30
EP0089597A2 (de) 1983-09-28
ES520706A0 (es) 1984-01-01
DK125583A (da) 1983-09-20
NO830966L (no) 1983-09-20
ES8401946A1 (es) 1984-01-01

Similar Documents

Publication Publication Date Title
FI832997A7 (fi) Vattenloesliga sampolymerer, deras framstaellning och anvaendning
FI830752L (fi) Karboxialkyldipeptider, foerfaranden foer deras framstaellning och farmaceutiska blandningar innehaollande dessa
FI831591A0 (fi) Azolylmetyloxiraner, deras framstaellningsfoerfarande och dessa innehaollande fungicider
FI830378L (fi) Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel
FI833398L (fi) Termiticidala atraktantfoereningar, kompositioner och foerfarande foer deras anvaendning
FI834888A0 (fi) Gonadoliberinderivat, foerfarande foer deras framstaellning och farmaceutiska och veterinaermedicinblandningar framstaellda daerav
FI842130L (fi) Reglerbar pao en baenk monterad bentraeningsanordning.
FI830457L (fi) Laosanordning, speciellt foer laemmar till lastflak och dylikt
FI832930L (fi) Aptitreducerande trifluormetylfenyltetrahydropyridiner, foerfarande foer deras framstaellning och farmaceutiska kompositioner
FI833647A7 (fi) Fenyl-indenderivat, deras syraadditionssalt och foerfarande foer deras framstaellning
FI834041L (fi) Bismaleimid innehaollande, vaermehaerdbara kompositioner och polymerer
FI831790L (fi) Piperazinderivat, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI833337A0 (fi) Heterocykliska foereningar, deras framstaellning, dessa innehaollande kompositioner och foerfarandekontrollering av ooenskad tillvaext av vaexter
FI830898A0 (fi) Sulfonylureor, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutiskaprodukter och deras anvaendning
FI830297L (fi) Benzotiennylallylaminer, foerfarande foer deras producering och deras anvaendning saosom laekemedel
FI831367A0 (fi) Pleuromutillinderivat, deras framstaellningsfoerfarande och farmaceutiska anvaendning
FI834112L (fi) Isoindolderivat, deras framstaellning och anvaendning
FI833119A7 (fi) Substituerade bensensulfonylsyraestrar, foerfaranden foer deras framstaellning och anvaendning daersom laekemedel
FI832789L (fi) Mjoeldrygealkaloider, deras framstaellning och anvaendning
FI833292A0 (fi) Piperidinderivat, deras framstaellning och anvaendning
FI834217L (fi) Materialsammansaettning baserad pao fraon vaexter haerstammande partiklar och foerfarande foer framstaellning av denna.
FI833102L (fi) Substituerade 1-pyridyloxi-3-indolylalkyl-amino-2-propanoler, deras framstaellning och anvaendning
FI832719A7 (fi) Foerbaettringar i keto-mellanprodukter, deras anvaendning och framstaellning
FI830206A0 (fi) Roterande, gaengfoersedd borrande och gaengbildande skruv
FI830992L (fi) 7- -aminoacyl-3-klorkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning solaekemedel

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT